Friday, September 24, 2021 12:36:09 PM
Having a contract manufacturer owned by the CEO of the company awarding them a contract for an undisclosed fee and using all the equipment paid for by NWBO shareholders in a building which we also pay the primary lease seems completely normal to you ?
I suspect they will eventually own the equipment and sub lease but only after they have certification and an agreed price to manufacture that repays us our initial capital outlay but removes the upside to shareholders…..and when that’s all repaid you are left with a gem of a company.
So £1.00 really can get you a profitable privately owned business with contracts that are both long term and potentially of significant value…..
Don’t you honestly think it will be preferable or not to own that in the first place considering we paid for it along with the self paying customers?
Do you not remember the famous - we are going it alone battle cry…..we will be a technology company owning patents and IP….with good revenues from selling DCVax for all shareholdersl but with a slice removed to cover all costs and make Advent a profitable valuable company in its own right, Just like Cognate.
I know you are a smart clinician but trying to say this is normal just ain’t believable because of the ownership structure….
I suspect they will eventually own the equipment and sub lease but only after they have certification and an agreed price to manufacture that repays us our initial capital outlay but removes the upside to shareholders…..and when that’s all repaid you are left with a gem of a company.
So £1.00 really can get you a profitable privately owned business with contracts that are both long term and potentially of significant value…..
Don’t you honestly think it will be preferable or not to own that in the first place considering we paid for it along with the self paying customers?
Do you not remember the famous - we are going it alone battle cry…..we will be a technology company owning patents and IP….with good revenues from selling DCVax for all shareholdersl but with a slice removed to cover all costs and make Advent a profitable valuable company in its own right, Just like Cognate.
I know you are a smart clinician but trying to say this is normal just ain’t believable because of the ownership structure….
Recent NWBO News
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
